| Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO VE Clark, EZ Erson-Omay, A Serin, J Yin, J Cotney, K Özduman, T Avşar, ... Science 339 (6123), 1077-1080, 2013 | 839 | 2013 |
| Partitioning of cancer therapeutics in nuclear condensates IA Klein, A Boija, LK Afeyan, SW Hawken, M Fan, A Dall'Agnese, O Oksuz, ... Science 368 (6497), 1386-1392, 2020 | 315 | 2020 |
| Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas VE Clark, AS Harmancı, H Bai, MW Youngblood, TI Lee, JF Baranoski, ... Nature genetics 48 (10), 1253-1259, 2016 | 314 | 2016 |
| Integrated genomic characterization of IDH1-mutant glioma malignant progression H Bai, AS Harmancı, EZ Erson-Omay, J Li, S Coşkun, M Simon, ... Nature genetics 48 (1), 59-66, 2016 | 307 | 2016 |
| Integrated genomic analyses of de novo pathways underlying atypical meningiomas AS Harmancı, MW Youngblood, VE Clark, S Coşkun, O Henegariu, ... Nature communications 8 (1), 14433, 2017 | 198* | 2017 |
| Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas MW Youngblood, D Duran, JD Montejo, C Li, SB Omay, K Özduman, ... Journal of neurosurgery 133 (5), 1345-1354, 2019 | 123 | 2019 |
| Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis EZ Erson-Omay, AO Çağlayan, N Schultz, N Weinhold, SB Omay, ... Neuro-oncology 17 (10), 1356-1364, 2015 | 121 | 2015 |
| Optimal surgical management of well-differentiated thyroid cancer arising in struma ovarii: a series of 4 patients and a review of 53 reported cases JL Marti, VE Clark, H Harper, DC Chhieng, JA Sosa, SA Roman Thyroid 22 (4), 400-406, 2012 | 92 | 2012 |
| Whole‐exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene CC Juhlin, A Stenman, F Haglund, VE Clark, TC Brown, J Baranoski, ... Genes, Chromosomes and Cancer 54 (9), 542-554, 2015 | 65 | 2015 |
| Genetic variation associated with condensate dysregulation in disease SF Banani, LK Afeyan, SW Hawken, JE Henninger, A Dall’Agnese, ... Developmental cell 57 (14), 1776-1788. e8, 2022 | 39 | 2022 |
| Impact of COVID-19 on neurosurgery resident research training VE Clark Journal of Neurosurgery 133 (1), 12-13, 2020 | 36 | 2020 |
| Longitudinal analysis of treatment-induced genomic alterations in gliomas EZ Erson-Omay, O Henegariu, SB Omay, AS Harmancı, MW Youngblood, ... Genome medicine 9, 1-10, 2017 | 25 | 2017 |
| Temporal requirement of the alternative-splicing factor Sfrs1for the survival of retinal neurons RN Kanadia, VE Clark, C Punzo, JM Trimarchi, CL Cepko Oxford University Press for The Company of Biologists Limited 135 (23), 3923 …, 2008 | 21 | 2008 |
| Extent of resection versus molecular classification: what matters when? VE Clark, DP Cahill Neurosurgery Clinics of North America 30 (1), 95-101, 2019 | 19 | 2019 |
| Absence of KMT2D/MLL2 mutations in abdominal paraganglioma A Stenman, CC Juhlin, F Haglund, TC Brown, VE Clark, F Svahn, ... Clinical endocrinology 84 (4), 632-634, 2016 | 6 | 2016 |
| Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomas MW Youngblood, Z Erson-Omay, C Li, H Najem, S Coșkun, E Tyrtova, ... Nature communications 14 (1), 6279, 2023 | 3 | 2023 |
| Clinical and molecular features of genomic subgroups in meningioma MW Youngblood, V Clark, AS Harmanci, H Bai, DD Mora, J Montejo, C Li, ... JOURNAL OF NEUROSURGERY 126 (4), A1424-A1424, 2017 | 2 | 2017 |
| Characterizing the Genomic Architecture and Molecular Mechanisms Driving the Formation of Non-NF2 Meningiomas VE Clark Yale University, 2015 | 1 | 2015 |
| OMICS AND PROGNSTIC MARKERS K Adachi, H Sasaki, S Nagahisa, K Yoshida, N Hattori, Y Nishiyama, ... Neuro-oncology 15 (Suppl 3), iii136-iii155, 2013 | 1 | 2013 |
| 203 RNA Polymerase II Meningioma Mutations Activate Forebrain Neurodevelopmental Pathways VE Clark, B Prager, S Wilson-Hawken, R Young Neurosurgery 70 (Supplement_1), 53, 2024 | | 2024 |
